ASSOCIATION OF CEREBRAL SMALL VESSEL DISEASE BURDEN WITH BRAIN STRUCTURE AND COGNITIVE AND VASCULAR RISK TRAJECTORIES IN MID-TO-LATE LIFE

• Michelle G. Jansen,
• Ludovica Griffanti,
• Clare E. Mackay,
• Melis Anatürk,
• Luca Melazzini,
• Ann-Marie G. de Lange,
• Nicola Filippini,
• Enikő Zsoldos,
• Kim Wiegertjes,
• Frank-Erik de Leeuw,
• Archana Singh-Manoux,
• Mika Kivimäki,
• Klaus P. Ebmeier,
• Sana Suri

Affiliations

Michelle G. Jansen

Donders Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands

Ludovica Griffanti

Department of Psychiatry, University of Oxford, United Kingdom; Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom

Clare E. Mackay

Department of Psychiatry, University of Oxford, United Kingdom; Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom

Melis Anatürk

Department of Psychiatry, University of Oxford, United Kingdom; Centre for Medical Image Computing, Department of Computer Science, University College London, United Kingdom

Luca Melazzini

Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy

Ann-Marie G. de Lange

Department of Psychiatry, University of Oxford, United Kingdom; Department of Psychology, University of Oslo, Norway

Nicola Filippini

Department of Psychiatry, University of Oxford, United Kingdom; Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom

Enikő Zsoldos

Department of Psychiatry, University of Oxford, United Kingdom; Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom

Kim Wiegertjes

Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands

Frank-Erik de Leeuw

Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands

Archana Singh-Manoux

Department of Epidemiology and Public Health, University College London, United Kingdom; Université de Paris, INSERM, U1153, Epidemiology of Ageing and Neurogenerative diseases, Paris, France

Mika Kivimäki

Department of Epidemiology and Public Health, University College London, United Kingdom

Klaus P. Ebmeier

Department of Psychiatry, University of Oxford, United Kingdom

Sana Suri

Department of Psychiatry, University of Oxford, United Kingdom; Wellcome Centre for Integrative Neuroimaging (Oxford Centres for Functional MRI of the Brain & Human Brain Activity) Nuffield Department of Clinical Neurosciences & Psychiatry, University of Oxford, United Kingdom